NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.
公司代碼NPCE
公司名稱Neuropace Inc
上市日期Apr 22, 2021
CEOBecker (Joel D)
員工數量184
證券類型Ordinary Share
年結日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94043
電話16502372700
網址https://www.neuropace.com/
公司代碼NPCE
上市日期Apr 22, 2021
CEOBecker (Joel D)